+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Kidney Function Tests Market Size, Share & Trends Analysis Report By Product (Clearance Tests, Urine Tests, Blood Tests), By End Use (Hospitals, Diagnostic Laboratories, Research Laboratories And Institutes), By Region, And Segment Forecasts, 2025 - 2030- Product Image
Kidney Function Tests Market Size, Share & Trends Analysis Report By Product (Clearance Tests, Urine Tests, Blood Tests), By End Use (Hospitals, Diagnostic Laboratories, Research Laboratories And Institutes), By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Kidney Function Tests Market Size, Share & Trends Analysis Report By Product (Clearance Tests, Urine Tests, Blood Tests), By End Use (Hospitals, Diagnostic Laboratories, Research Laboratories And Institutes), By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • January 2025
  • Region: Global
  • Grand View Research
  • ID: 4209720
Description Jump to:
The global kidney function tests market size is expected to reach USD 1.39 billion by 2030, registering at a CAGR of 6.7% from 2025 to 2030. Key factors such as high prevalence of kidney diseases, the rising R&D activities, increasing investments by market players, and technological innovations are anticipated to significantly drive the market growth. Moreover, the growing number of initiatives undertaken by the government to provide various facilities, such as reimbursement for diagnostic tests is a major factor likely to boost the market.

Introduction of innovative kidney function tests in the market by the operating players is increasing the adoption of these diagnostics tests. For instance, in December 2022, Journey Biosciences, Inc. launched its leading product-NaviDKD. It is a biomarker-based blood test, which evaluates the peril of renal disease in people with diabetes years before the symptoms appear. Along with its patented compass reporting platform, the product provides actionable insights for managing and preventing complications before they arise. Such developments are foreseen to fuel the market during the forecast period.

Furthermore, rising R&D initiatives for the development of novel products are expected to significantly fuel the market growth during the forecast period. For instance, in February 2021, Researchers from the University Hospitals of Derby and Burton, NHS Foundation Trust, and the University of Nottingham received USD 2.32 million in funding to help improve the treatment and diagnosis of renal diseases. Researchers will use multi-parametric MRI scanning to evaluate patients suffering from CKD. Similarly, the Canadian kidney research organization received a new USD 11.8 million investment to support its work through 2027. The Can-SOLVE Chronic Kidney Disease Network is the largest-ever kidney research initiative in Canada.

The COVID-19 pandemic has been associated with increase in hospitalization and infection hotspots around the country. There were at least three separate waves of COVID-19 around the world by June 2021 that put a significant strain on hospital resources, especially labor and availability of dialysis equipment & supplies. In addition, the COVID-19 pandemic has affected healthcare services for renal disease patients. Social distancing and lockdown were mandate norms, globally, leading to temporary closure of other medical services. The diagnosis of several renal diseases deferred during the pandemic due to suspension of non-urgent visits and testing services.

Moreover, the growing prevalence of renal diseases is projected to increase the demand for diagnostic tests during the study period. For instance, according to The National Kidney Foundation, Inc., an estimated 37 million people in the U.S., i.e., more than one in seven adults, are living with some form of renal disease. Similarly, according to data published by FDA, about 10,000 children in the U.S. develop acute kidney infections (AKI) every year. These children possess a survival rate of around 38%-43%. The mortality rate for neonates with AKI is around 60%. Such factors are likely to drive the demand for neonatal hemodialysis, thereby driving the market growth.

On the other hand, low awareness regarding renal diseases is expected to hamper the market growth. For instance, In the U.S., an estimated 37 million adults have kidney disease and about 90% remain unaware of the condition. Major risk factors for the disease are high blood pressure and diabetes as well as heart disease, obesity, & family history of kidney disease. However, various government bodies are initiating programs for raising awareness of kidney function tests. For instance, Tamilnadu Kidney Research Foundation has conducted 1,279 awareness programs until March 2020.

Kidney Function Tests Market Report Highlights

  • By product, the clearance tests segment held the largest share of the market. These tests ensure that there is minimal variation in performance owing to their optimum sensitivity and precision. The low cost and easy availability of these products in the market lead to their increased adoption.
  • By end-user, the hospitals segment accounted for the dominant market share in 2024, due to the rising demand for IVD tests because of increase in the prevalence of CKD.
  • North America dominated the global market in 2024 due to the well-established healthcare infrastructure, favorable reimbursement policies and government initiatives in the region.
  • Asia Pacific is expected to grow considerably in the future owing to the increasing awareness programs about CKD in emerging economies, such as China & India.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End use
1.2.3. Application
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End use outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Kidney Function Tests Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Introduction Of Innovative Kidney Function Tests
3.2.1.2. Increasing Investments In R&D
3.2.1.3. Increasing Prevalence Of Acute Kidney Injury And Associated Chronic Kidney Disease
3.2.2. Market restraint analysis
3.2.2.1. Low Awareness Regarding Kidney Diseases
3.3. Kidney Function Tests Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Kidney Function Tests Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Kidney Function Tests Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Clearance Tests
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
4.4.2. Blood Tests
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Urine Tests
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Dilution & Concentration Tests
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Other Tests
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Kidney Function Tests Market: End Use Estimates & Trend Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Kidney Function Tests Market by End Use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Hospitals
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
5.4.2. Diagnostic Laboratories
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Research Laboratories And Institutes
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Others
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Kidney Function Tests Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/ reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/ reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/ reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/ reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key company market share analysis, 2024
7.3.2. Danaher
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Danaher
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. F. Hoffmann-La Roche Ltd
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Sysmex Corporation
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Siemens Healthineers
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Randox Laboratories Ltd
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Quest Diagnostics
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Acon Laboratories, Inc
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Nova Biomedical Corporation
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Laboratory Corporation Of America Holdings
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
List of Tables
Table 1 Premarket approval process
Table 2 Key companies adopting expansion strategy
Table 3 Key companies adopting collaboration strategy
Table 4 Key companies launching new products/services
Table 5 Key companies adopting partnership strategy
Table 6 List of Secondary Sources
Table 7 List of Abbreviations
Table 8 Global Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 9 Global Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 10 Global Kidney Function Tests Market, by Region, 2018 - 2030 (USD Million)
Table 11 North America Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
Table 12 North America Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 13 North America Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 14 U.S Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 15 U.S Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 16 Canada Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 17 Canada Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 18 Mexico Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 19 Mexico Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 20 Europe Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
Table 21 Europe Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 22 Europe Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 23 Germany Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 24 Germany Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 25 UK Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 26 UK Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 27 France Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 28 France Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 29 Italy Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 30 Italy Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 31 Spain Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 32 Spain Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 33 Denmark Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 34 Denmark Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 35 Sweden Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 36 Sweden Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 37 Norway Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 38 Norway Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 39 Asia Pacific Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
Table 40 Asia Pacific Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 42 Japan Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 43 Japan Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 44 China Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 45 China Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 46 India Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 47 India Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 48 South Korea Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 49 South Korea Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 50 Australia Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 51 Australia Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 52 Singapore Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 53 Singapore Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 54 Thailand Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 55 Thailand Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 56 Latin America Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
Table 57 Latin America Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 58 Latin America Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 59 Brazil Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 60 Brazil Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 61 Argentina Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 62 Argentina Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 63 Middle East & Africa Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
Table 64 Middle East & Africa Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 65 Middle East & Africa Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 66 South Africa Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 67 South Africa Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 68 Saudi Arabia Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 69 Saudi Arabia Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 70 UAE Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 71 UAE Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
Table 72 Kuwait Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
Table 73 Kuwait Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Executives contacted
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Kidney function tests market estimation process
Fig. 10 Market snapshot
Fig. 11 Market segmentation and scope
Fig. 12 Penetration and growth prospect mapping
Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 14 Porter’s five forces analysis
Fig. 15 Market drivers impact
Fig. 16 Reported causes of end-stage renal disease in the U.S.
Fig. 17 Percentage of U.S. adults aged 18 or older with CKD
Fig. 18 Market restraint relevance analysis (Current & future impact)
Fig. 19 Kidney function test market: product outlook and key takeaways
Fig. 20 Kidney function tests market: product movement analysis
Fig. 21 Clearance tests market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Blood tests market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Urine tests market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Dilution & concentration tests market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Other tests market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Kidney function test market: end-use outlook and key takeaways
Fig. 27 Kidney function test market: end-use movement analysis
Fig. 28 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Diagnostic laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Research laboratories and institutes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Regional marketplace: key takeaways
Fig. 33 North America kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 U.S. kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Canada kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Mexico kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Europe kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Germany kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 UK kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 France kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Italy kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Spain kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Denmark kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Sweden kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Norway kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Asia Pacific kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Japan kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 China kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 India kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 South Korea kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Australia kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Thailand kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Singapore kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Latin America kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Brazil kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Argentina kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Middle East and Africa kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 South Africa kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 UAE kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Saudi Arabia kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Kuwait kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Market participant categorization
Fig. 63 Kidney function tests market share analysis, 2024
Fig. 64 Strategic framework

Companies Mentioned

  • Abbott
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Sysmex Corporation
  • Siemens Healthineers
  • Randox Laboratories Ltd
  • Quest Diagnostics
  • Acon Laboratories, Inc.
  • Nova Biomedical Corporation
  • Laboratory Corporation Of America Holdings

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedJanuary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 0.95 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.39 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Kidney Function Tests Market by Product, End-Use - Global Forecast 2025-2030 - Product Image

Kidney Function Tests Market by Product, End-Use - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Kidney Function Tests - Global Strategic Business Report - Product Image

Kidney Function Tests - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Kidney Function Test Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Kidney Function Test Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 84 Pages
  • Global
From
2024 Global Forecast for Kidney/Renal Function Test Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Kidney/Renal Function Test Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
2024 Global Forecast for Kidney Function Tests Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Kidney Function Tests Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.